Join to View Full Profile
240 W Thomas RdSte 400Phoenix, AZ 85013
Phone+1 602-406-6262
Fax+1 602-406-6261
Dr. Shefner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 1988 - 1990- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1987 - 1988
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1984 - 1986
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1983 - 1984
Northwestern University The Feinberg School of MedicineClass of 1983
Certifications & Licensure
AZ State Medical License 2014 - 2026
MA State Medical License 1985 - 2017
NY State Medical License 1996 - 2016
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Best Doctors Best Doctors, 2007-2016
- Sheila Essey Award for ALS Research American Academy of Neurology, ALS Association, 2014
- America's Top Doctors Castle Connolly, 2009-2014
Clinical Trials
- A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS Start of enrollment: 2005 Oct 01
- A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
- Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-04-01 - Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Ammar Al-Chalabi
JAMA Neurology. 2025-03-24 - Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label Study.Marc Gotkine, David A Schoenfeld, Ilana Cohen, Jeremy M Shefner, Yossef Lerner
Muscle & Nerve. 2025-03-19
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
HEALEY ALS Trial: Pridopidine Shows No Impact on Disease Progression in ALSApril 17th, 2025- Trial Data Shed Light on ALS Clinical ResearchMarch 24th, 2025
- NeuroSense Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis and Frontotemporal DegenerationSeptember 19th, 2022
- Join now to see all
Grant Support
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
